Ende Yang

447 total citations
9 papers, 97 citations indexed

About

Ende Yang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Ende Yang has authored 9 papers receiving a total of 97 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 2 papers in Surgery. Recurrent topics in Ende Yang's work include RNA modifications and cancer (2 papers), Myasthenia Gravis and Thymoma (2 papers) and Esophageal Cancer Research and Treatment (2 papers). Ende Yang is often cited by papers focused on RNA modifications and cancer (2 papers), Myasthenia Gravis and Thymoma (2 papers) and Esophageal Cancer Research and Treatment (2 papers). Ende Yang collaborates with scholars based in China and United States. Ende Yang's co-authors include Xin Jing, Yun Wang, Bo Yang, Hong Ren, Jennifer A. Pietenpol, Karl Münger, Connor Murphy, Harold L. Moses, Xiang Ji and Yunyun Zhou and has published in prestigious journals such as The Annals of Thoracic Surgery, Tumor Biology and International Journal of Surgery.

In The Last Decade

Ende Yang

8 papers receiving 96 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ende Yang China 6 51 43 32 23 15 9 97
Sophie Locke Germany 4 77 1.5× 47 1.1× 36 1.1× 8 0.3× 9 0.6× 4 122
Monica T. Hannani Denmark 3 43 0.8× 38 0.9× 32 1.0× 9 0.4× 15 1.0× 5 97
Francesca Maremonti Germany 5 87 1.7× 64 1.5× 47 1.5× 10 0.4× 13 0.9× 8 148
José Ignacio Arias Pérez Spain 6 63 1.2× 20 0.5× 85 2.7× 44 1.9× 31 2.1× 10 142
Jigjidsuren Chinburen Mongolia 5 27 0.5× 27 0.6× 24 0.8× 13 0.6× 17 1.1× 9 108
Georg B. Gruber Austria 6 25 0.5× 12 0.3× 16 0.5× 35 1.5× 12 0.8× 23 99
Yuanqiang Dong China 7 56 1.1× 31 0.7× 40 1.3× 28 1.2× 13 0.9× 9 107
Shuting Tang China 5 93 1.8× 20 0.5× 67 2.1× 15 0.7× 19 1.3× 13 149
Liubov A. Ponomareva Russia 3 42 0.8× 56 1.3× 35 1.1× 3 0.1× 7 0.5× 12 83
Alberto Caligiana Italy 4 43 0.8× 35 0.8× 12 0.4× 6 0.3× 9 0.6× 5 100

Countries citing papers authored by Ende Yang

Since Specialization
Citations

This map shows the geographic impact of Ende Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ende Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ende Yang more than expected).

Fields of papers citing papers by Ende Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ende Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ende Yang. The network helps show where Ende Yang may publish in the future.

Co-authorship network of co-authors of Ende Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Ende Yang. A scholar is included among the top collaborators of Ende Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ende Yang. Ende Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Lan, Ke, Xiaolong Yan, Jie Lei, et al.. (2024). Clinical outcomes and short-term survival of neoadjuvant immunochemotherapy for resectable esophageal cancer: a multicenter retrospective cohort study. International Journal of Surgery. 111(1). 1547–1551.
2.
Jing, Xin, et al.. (2023). Pyroptosis and Inflammasome-Related Genes-NLRP3, NLRC4 and NLRP7 Polymorphisms Were Associated with Risk of Lung Cancer. Pharmacogenomics and Personalized Medicine. Volume 16. 795–804. 7 indexed citations
3.
Wang, Yun, et al.. (2022). Cuproptosis-Related Gene – SLC31A1, FDX1 and ATP7B – Polymorphisms are Associated with Risk of Lung Cancer. Pharmacogenomics and Personalized Medicine. Volume 15. 733–742. 41 indexed citations
4.
Yang, Ende, et al.. (2022). Exosomal miR-181a-3p Regulates the Anlotinib Resistance of Lung Cancer Cells. Journal of Biomaterials and Tissue Engineering. 12(9). 1799–1804. 1 indexed citations
5.
Zhao, Jinbo, Ying Han, Yunyun Zhou, et al.. (2016). Simultaneous esophagectomy and off-pump coronary artery bypass grafting: a practicable approach with good survival. Diseases of the Esophagus. 30(1). n/a–n/a. 11 indexed citations
6.
Yang, Bo, et al.. (2015). ARNT2 is downregulated and serves as a potential tumor suppressor gene in non-small cell lung cancer. Tumor Biology. 36(3). 2111–2119. 16 indexed citations
7.
Lü, Qiang, et al.. (2013). Spontaneous Rupture of a Giant Intrapericardial Bronchogenic Cyst. The Annals of Thoracic Surgery. 96(5). e109–e110. 3 indexed citations
8.
Li, Z., et al.. (2011). Gigantic intrapericardial bronchogenic cyst. Netherlands Heart Journal. 19(12). 532–533. 6 indexed citations
9.
Moses, Harold L., Jennifer A. Pietenpol, Karl Münger, Connor Murphy, & Ende Yang. (1991). TGF beta regulation of epithelial cell proliferation: role of tumor suppressor genes.. PubMed. 22. 183–95. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026